Pasithea Therapeutics' abstract on PAS-004 has been accepted for poster presentation at the ASCO 2024 Annual Meeting. Join us to learn about our macrocyclic MEK inhibitor for the treatment of NF1 and other indications.?#ASCO2024 #NF1 #PAS004 #MEKInhibitor https://lnkd.in/ezwxyi2H
关于我们
Strategic financial communications, investor relations, and capital advisory, for development and growth-stage companies. Corporate capital strategy and execution experience translates to clear insight into how enterprises grow. Tech and healthcare growth finance expertise from decades experience as formerly registered investment bankers, and in PR and corporate branding.
- 网站
-
www.growthcapreport.com
Growth Cap Report的外部链接
- 所属行业
- 公共关系和沟通服务
- 规模
- 2-10 人
- 总部
- New York，NY
- 类型
- 私人持股
- 创立
- 2014
- 领域
- Stocks、Capital Markets、Biotech、Digital Health、Financial Communication、Media Relations、Growth Finance和IPO
地点
-
主要
获取路线
1732 1st Ave
20260
US，NY，New York，10128